Marketing-authorisation holder
Nuron Biotech B.V.
2 medicines in 2 countries, as authorisation holder and marketer.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| MENINGITEC15 mcg / 0.5 ml + 10 mcg / 0.5 ml · Suspension | Corynebacterium diphtheriae crm-197 protein, Meningococcal group c oligosaccharide | Canada | Cancelled | 2004 |
| MENINGITEC SUSPENSION PARA INYECCION EN JERINGA PRECARGADA10 µg + 15 µg · Suspensión inyectable en jeringa precargada | Antigeno oligosacarido meningococo grupo c, Corynebacterium diphtheriae crm-197 protein | Spain | Suspended | 2007 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 1 | 0 | 1 | CompaniesAll medicines |
| Spain | 1 | 0 | 1 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- VaccinesAnti-infectives for systemic use · ATC J07A
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- nuron biotech
- nuron biotech b v
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 2
- Countries
- 2
- Roles
- Authorisation holder and marketer